0001628280-24-007998.txt : 20240229
0001628280-24-007998.hdr.sgml : 20240229
20240229162656
ACCESSION NUMBER: 0001628280-24-007998
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOYER ANDREW S
CENTRAL INDEX KEY: 0001239546
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 24704138
MAIL ADDRESS:
STREET 1: C/O WATSON PHARMA INC
STREET 2: 360 MOUNT KEMBLE AVE
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
wk-form4_1709241999.xml
FORM 4
X0508
4
2024-02-27
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001239546
BOYER ANDREW S
C/O AMNEAL PHARMACEUTICALS, INC.
BRIDGEWATER
NJ
08807
0
1
0
0
Executive Vice President
0
Class A Common Stock
2024-02-27
4
M
0
31663
A
276402
D
Class A Common Stock
2024-02-27
4
F
0
16556
5.71
D
259846
D
Restricted Stock Units
2024-02-27
4
M
0
31663
0
D
Class A Common Stock
31663
0
D
Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
/s/ Denis Butkovic, Attorney-in-Fact
2024-02-29